Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,927,088
-
Share change
-
+635,826
-
Total reported value
-
$1,422,532,387
-
Put/Call ratio
-
56%
-
Price per share
-
$95.30
-
Number of holders
-
70
-
Value change
-
+$61,456,276
-
Number of buys
-
29
-
Number of sells
-
34
Institutional Holders of CHINA BIOLOGIC PRODS HLDGS I - COM (CBPO) as of Q2 2019
As of 30 Jun 2019,
CHINA BIOLOGIC PRODS HLDGS I - COM (CBPO) was held by
70 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,927,088 shares.
The largest 10 holders included
Capital Research Global Investors, HILLHOUSE CAPITAL ADVISORS, LTD., York Capital Management Global Advisors, LLC, HSBC HOLDINGS PLC, Temasek Holdings (Private) Ltd, VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, Greenwoods Asset Management Ltd, FIL Ltd, and NORGES BANK.
This page lists
70
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.